Description

Vander Poorten et al developed 2 prognostic scores for patients with parotid carcinoma. The first used clinical information while the second included information from the pathologic examination of the tumor. The work was done at the Netherlands Cancer Institute in Amsterdam.


Prognostic Score from Clinical Findings (PS1)

 

Parameter

Finding

Points

age at diagnosis

age in years

age

pain on presentation

no pain

1

 

pain or numbness

2

T status of clinical TNM

T1

0

 

T2

1

 

T3

2

 

T4

3

N status of clinical TNM

N0

0

 

N1

1

 

N2a

2

 

N2b

3

 

N2c

4

 

N3

5

skin invasion

no invasion

1

 

present

2

facial nerve dysfunction

intact function

1

 

paresis and/or paralysis

2

 

prognostic score 1 (PS1) =

= (0.024 * (age in years)) +  (0.62 * (points for pain)) +  (0.44 * (points for T status)) +  (0.45 * (points for N status)) +  (0.63 * (points for skin invasion)) +  (0.91 * (points for facial nerve dysfunction))

 

Interpretation:

• minimum score: around 2.64

• maximum score: around 10

• 4 prognostic groups identified with different 5 year recurrence free survival.

 

PS1

Group

5 year recurrence free rates (95% CI)

< 3.85

1

92.4% (73.0-98.1%)

3.85 - 4.74

2

82.5% (62.8-92.4%)

4.75 - 5.80

3

48.1% (26.1 - 67.1%)

> 5.80

4

22.8% (8.5-41.2%)

 

Prognostic Score After Examination of Resected Specimen (PS2)

 

Parameter

Finding

Points

age at diagnosis

age in years

age

T status of clinical TNM

T1

0

 

T2

1

 

T3

2

 

T4

3

N status of clinical TNM

N0

0

 

N1

1

 

N2a

2

 

N2b

3

 

N2c

4

 

N3

5

skin invasion

no invasion

1

 

present

2

facial nerve dysfunction

intact function

1

 

paresis and/or paralysis

2

perineural growth in the resected specimen

no

1

 

yes

2

positive surgical margins

no

1

 

yes

2

 

prognostic score 2 (PS2) =

= (0.018 * (age in years)) +  (0.39 * (points for T status)) +  (0.34 * (points for N status)) +  (0.70 * (points for skin invasion)) +  (0.56 * (points for facial nerve dysfunction)) + (0.78 * (points for perineural growth)) + (0.65 * (points for positive margin))

 

Interpretation:

• minimum score: around 2.35

• maximum score: around 10

• 4 prognostic groups identified with different 5 year recurrence free survival.

 

PS2

Group

5 year recurrence free rates (95% CI)

< 3.99

1

95% (69.5-99.3%)

3.99 - 4.80

2

82.5% (59.8-93.1%)

4.81 - 5.67

3

55.9% (30.8 - 75.1%)

> 5.67

4

42% (21.9-60.9%)

 


To read more or access our algorithms and calculators, please log in or register.